Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.22 | 0.08 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |